Bosutinib is an inhibitor of CDK2 for chronic granulomatous leukemia treatment [45], and fostamatinib is an inhibitor of AURKB for persistent/chronic adult immune thrombocytopenia treatment [46]. The gene discussed is CDK2; the disease is autoimmune thrombocytopenic purpura.